STERIS plc presents a reliable dividend profile characterized by consistent payments and moderate growth over recent years. The company has maintained a stable dividend distribution for over two decades, suggesting a strong commitment to returning capital to shareholders. With a current dividend yield of just over 1%, investors might be looking for more substantial income sources, but STERIS's growth trajectory in dividend payouts remains a positive aspect.
STERIS plc is situated in the Healthcare sector, offering moderate but consistent dividend payouts.
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Dividend yield | 1.00% |
| Current dividend per share | 2.23 USD |
| Dividend history | 22 years |
| Last cut or suspension | None |
The historical dividend record of STERIS plc is indicative of its consistent financial performance and firm dedication to shareholder returns, which enhances investor confidence.
| Year | Dividend per Share (USD) |
|---|---|
| 2026 | 0.63 |
| 2025 | 2.40 |
| 2024 | 2.18 |
| 2023 | 1.98 |
| 2022 | 1.80 |
The dividend growth metrics demonstrate STERISβs ability to incrementally enhance its shareholder distribution, providing an indicator of financial health and earning capacity.
| Time | Growth |
|---|---|
| 3 years | 10.06% |
| 5 years | 9.28% |
The average dividend growth is 9.28% over 5 years. This shows moderate but steady dividend growth.
A balanced payout ratio provided by STERIS plc ensures the sustainability of its dividend payments and highlights efficient capital allocation.
| Key figure ratio | Value |
|---|---|
| EPS-based | 31.88% |
| Free cash flow-based | 22.86% |
The moderate EPS payout ratio of 31.88% and the conservative free cash flow payout of 22.86% suggest robust financial health with a margin for reinvestment and growth.
Examining STERIS's cash flow metrics is integral to understanding its operational efficacy and ability to fund dividends and growth simultaneously through efficient capital management.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Free Cash Flow Yield | 3.48% | 2.81% | 2.07% |
| Earnings Yield | 2.75% | 1.73% | 0.56% |
| CAPEX to Operating Cash Flow | 32.24% | 37.02% | 47.82% |
| Stock-based Compensation to Revenue | 1.05% | 1.10% | 0.86% |
| Free Cash Flow / Operating Cash Flow Ratio | 67.76% | 62.98% | 52.18% |
The analysis of cashflow dynamics indicates commendable capital efficiency, supporting solid liquidity with room for expanding investments.
The balance sheet metrics shed light on STERIS's leverage and capital structure, ensuring the company remains well-poised to weather economic downturns.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Debt-to-Equity | 0.33 | 0.54 | 0.53 |
| Debt-to-Assets | 0.22 | 0.31 | 0.30 |
| Debt-to-Capital | 0.25 | 0.35 | 0.35 |
| Net Debt to EBITDA | 1.49 | 2.25 | 2.26 |
| Current Ratio | 1.96 | 3.08 | 2.33 |
| Quick Ratio | 1.39 | 2.36 | 1.63 |
| Financial Leverage | 1.54 | 1.76 | 1.78 |
STERIS's controlled leveraging strategy ensures adequate liquidity and minimizes financial risk, reflecting a stable and balanced financial approach.
Assessing profitability and return metrics affirms STERIS's operational efficiency and capacity to generate profits, which are crucial for sustained growth and investment attraction.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Return on Equity | 9.31% | 6.00% | 1.76% |
| Return on Assets | 6.06% | 3.42% | 0.99% |
| Net Margin | 11.26% | 7.36% | 2.36% |
| EBIT Margin | 16.16% | 16.49% | 17.44% |
| EBITDA Margin | 24.89% | 27.49% | 29.63% |
| Gross Margin | 44.01% | 43.17% | 43.66% |
| R&D to Revenue | 1.97% | 2.02% | 2.17% |
Profitability ratios illustrate a sound corporate governance policy and operational robustness, essential for competitiveness and future expansion.
| Criterion | Score | Score Bar |
|---|---|---|
| Dividend yield | 3 | |
| Dividend Stability | 5 | |
| Dividend growth | 4 | |
| Payout ratio | 5 | |
| Financial stability | 5 | |
| Dividend continuity | 5 | |
| Cashflow Coverage | 4 | |
| Balance Sheet Quality | 5 |
STERIS plc's dividend profile is characterized by high stability and gradual growth, making it an appealing pick for long-term investors seeking reliable income. With robust fundamentals and a forward-thinking growth strategy, STERIS holds its ground as a compelling investment within its sector.